Omar L. Francone

6.2k citations

71 papers · 5.2k indexed · 1 hit paper · h-index 34

Surgery top 0.5%
Molecular Biology top 2%
Oncology top 2%
Endocrinology, Diabetes and Metabolism top 1%
Cancer Research top 2%

Co-authors: Lori Royer Robert J. Aiello Mehrdad Haghpassand Patricia-Ann K. Bourassa Dominique Brees George H. Rothblat Alan R. Tall Kenneth L. Hoppe
Topics: Cholesterol and Lipid Metabolism (33 papers)Peroxisome Proliferator-Activated Receptors (25 papers)Drug Transport and Resistance Mechanisms (19 papers)
Cited by: Surgery Endocrinology, Diabetes and Metabolism Biochemistry
Journals: Science Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States France United Kingdom

In The Last Decade

Omar L. Francone

71 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation

2005 705 citations Matthew A. Kennedy, Kotoka Nakamura et al. Cell Metabolism profile →

Peers

Countries citing papers authored by Omar L. Francone

Since Specialization

Citations

This map shows the geographic impact of Omar L. Francone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar L. Francone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar L. Francone more than expected).

Fields of papers citing papers by Omar L. Francone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar L. Francone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar L. Francone. The network helps show where Omar L. Francone may publish in the future.

Co-authorship network of co-authors of Omar L. Francone

This figure shows the co-authorship network connecting the top 25 collaborators of Omar L. Francone. A scholar is included among the top collaborators of Omar L. Francone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar L. Francone. Omar L. Francone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained Correction of a Murine Model of Phenylketonuria following a Single Intravenous Administration of AAVHSC15-PAH 2020 ·Molecular Therapy — Methods & Clinical Development ·Seemin Seher Ahmed,Hillard Rubin,Minglun Wang,(unknown),(unknown),Serena Dollive,(unknown),Jeff L. Ellsworth,(unknown),Maria Lobikin,(unknown),(unknown),Teresa L. Wright,Albert Seymour,Omar L. Francone	21
2	Structure of the lipoprotein lipase–GPIHBP1 complex that mediates plasma triglyceride hydrolysis 2018 ·Proceedings of the National Academy of Sciences ·Gabriel Birrane,Anne P. Beigneux,Brian Dwyer,(unknown),Kristian Kølby Kristensen,Omar L. Francone,Loren G. Fong,Haydyn D. T. Mertens,Clark Q. Pan,Michael Ploug,Stephen G. Young,M. Muthuraman	63
3	Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility 2013 ·Xenobiotica ·Amit S. Kalgutkar,Kosea S. Frederick,Heather L. Hatch,Catherine M. Ambler,David A. Perry,Ravi S. Garigipati,George Chang,Bruce A. Lefker,Ronald W. Clark,Lee A. Morehouse,Omar L. Francone,Xiao Hu	2
4	Elucidation of the biochemical basis for a clinical drug–drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778 875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha 2013 ·Xenobiotica ·Amit S. Kalgutkar,Danny Chen,Manthena V. S. Varma,Bo Feng,Steven G. Terra,Renato J. Scialis,Charles J. Rotter,Kosea S. Frederick,Mark A. West,Theunis C. Goosen,J Gosset,Robert L. Walsky,Omar L. Francone	5
5	Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection 2009 ·Journal of Lipid Research ·Ronald W. Clark,David Cunningham,Cong Yang,Timothy A. Subashi,George T. Tkalcevic,David B. Lloyd,James G. Boyd,Boris A. Chrunyk,George A. Karam,Xiayang Qiu,Ing-Kae Wang,Omar L. Francone	21
6	Pharmacokinetics, disposition and lipid-modulating activity of 5-{2-[4-(3,4-difluorophenoxy)-phenyl]-ethylsulfamoyl}-2-methyl-benzoic acid, a potent and subtype-selective peroxisome proliferator-activated receptor α agonist in preclinical species and human 2009 ·Xenobiotica ·Kosea S. Frederick,Tristan S. Maurer,Amit S. Kalgutkar,Lori Royer,Omar L. Francone,Steven M. Winter,Steven G. Terra,(unknown),Xiang Gao	6
7	Molecular Characterization of Novel and Selective Peroxisome Proliferator-Activated Receptor α Agonists with Robust Hypolipidemic Activity in Vivo 2008 ·Molecular Pharmacology ·Christopher D. Kane,Kimberly A. Stevens,(unknown),Mehrdad Haghpassand,Lori Royer,Charles E. Aldinger,Katherine T. Landschulz,Panayiotis Zagouras,Scott W. Bagley,(unknown),Robert Dullea,Cheryl M. Hayward,Omar L. Francone	18
8	Efficacy and Safety of a Potent and Selective Peroxisome Proliferator Activated Receptor Alpha Agonist in Subjects With Dyslipidemia and Type 2 Diabetes Mellitus 2008 ·The American Journal of Cardiology ·Steven G. Terra,Omar L. Francone,Charles F. Contant,Xiang Gao,Andrew Lewin,Tu T. Nguyen	9
9	Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARα 2006 ·Gene ·Christopher D. Kane,Omar L. Francone,Kimberly A. Stevens	29
10	ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulationbreakdown → 2005 ·Cell Metabolism ·Matthew A. Kennedy,(unknown),Kotoka Nakamura,Ángel Baldán,Paul T. Tarr,Michael C. Fishbein,Joy S. Frank,Omar L. Francone,Peter A. Edwards	705
11	Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects 2003 ·Atherosclerosis ·Natalie Fournier,Omar L. Francone,George H. Rothblat,Dominique Goudounèche,Michèle Cambillau,Ginny Kellner-Weibel,Peggy Robinet,Lori Royer,N. Moatti,Alain Simon,Jean‐Louis Paul	41
12	Effects of Enrichment of Fibroblasts with Unesterified Cholesterol on the Efflux of Cellular Lipids to Apolipoprotein A-I 2002 ·Journal of Biological Chemistry ·Kristin Gillotte-Taylor,Margaret Nickel,William J. Johnson,Omar L. Francone,Paul Holvoet,Sissel Lund‐Katz,George H. Rothblat,Michael C. Phillips	44
13	The Correlation of ATP-binding Cassette 1 mRNA Levels with Cholesterol Efflux from Various Cell Lines 2000 ·Journal of Biological Chemistry ·Anna E. Bortnick,George H. Rothblat,Genevieve Stoudt,Kenneth L. Hoppe,Lori Royer,John McNeish,Omar L. Francone	272
14	Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice 1999 ·Journal of Biological Chemistry ·Yukihiko Ueda,Lori Royer,Elaine L. Gong,Junli Zhang,(unknown),Omar L. Francone,Edward M. Rubin	197
15	Secretion of Lecithin:Cholesterol Acyltransferase by Brain Neuroglial Cell Lines 1999 ·Biochemical and Biophysical Research Communications ·Xavier Collet,Omar L. Francone,François Besnard,Christopher J. Fielding	17
16	Disruption of the Murine Lecithin:Cholesterol Acyltransferase Gene Causes Impairment of Adrenal Lipid Delivery and Up-regulation of Scavenger Receptor Class B Type I 1997 ·Journal of Biological Chemistry ·Dominic S. Ng,Omar L. Francone,Trudy M. Forte,(unknown),Mehrdad Haghpassand,Edward M. Rubin	121
17	Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. 1996 ·Journal of Clinical Investigation ·Xian Jiang,Omar L. Francone,Can Bruce,R W Milne,Javier Mar,A Walsh,Jan L. Breslow,Alan R. Tall	159
18	Structure-function relationships in human lecithin:cholesterol acyltransferase. Site-directed mutagenesis at serine residues 181 and 216 1991 ·Biochemistry ·Omar L. Francone,Christopher J. Fielding	63
19	Concomitant Inhibition of VLDL Triglyceride and Apoprotein Secretion by Hepatocytes of Rats Adapted to a High-Fat Diet 1990 ·Advances in experimental medicine and biology ·Omar L. Francone,(unknown),(unknown)	4
20	Contribution of cytoplasmic storage triacylglycerol to VLDL-triacylglycerol in isolated rat hepatocytes 1989 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·Omar L. Francone,Athina-Despina Kalopissis,(unknown)	55

About Omar L. Francone

Omar L. Francone is a scholar working on Biochemistry, Surgery and Endocrinology, Diabetes and Metabolism, having authored 71 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (33 papers), Peroxisome Proliferator-Activated Receptors (25 papers) and Drug Transport and Resistance Mechanisms (19 papers). The work is most often cited by research in Surgery (3.6k citations), Endocrinology, Diabetes and Metabolism (1.3k citations) and Biochemistry (528 citations). Omar L. Francone has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Lori Royer, Robert J. Aiello, Mehrdad Haghpassand, Patricia-Ann K. Bourassa, Dominique Brees, George H. Rothblat, Alan R. Tall, Kenneth L. Hoppe, Edward M. Rubin and John McNeish. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact